TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04507360

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Study 1, Tailored Response
Description: Participants will be provided with a response to screening that is tailored to the match between screening score (above or below depression criteria) and expressed need for mental health support (yes or no).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Study 1, Generic Resources
Description: Participants will be provided with links to a list of 4 generic Mental Health America (MHA) resources.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Study 1, Generic Resources
Description: Participants will be provided with links to a list of 4 generic Mental Health America (MHA) resources.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Study 1, Tailored Resources by Desired Resources
Description: Participants will be provided with links to Mental Health America (MHA) resources aligned with their expressed interest (e.g., additional screening, self help tools).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Study 1, Tailored Resources by Desired Resources
Description: Participants will be provided with links to Mental Health America (MHA) resources aligned with their expressed interest (e.g., additional screening, self help tools).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Study 1, Embedded single-question DIY
Description: A single Do-It-Yourself (DIY) question will be embedded within the content page.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Study 1, Embedded full DIY within content page
Description: The full Do-It-Yourself (DIY) tool will be embedded within the content page.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Study 1, Single question plus full DIY
Description: A single question plus the full Do-It-Yourself (DIY) tool will be embedded within the content page.
Study: NCT05401851

Intervention type: DEVICE
Group type: OTHER
Intervention: Left Bundel Area Pacing
Description: RV Lead will be placed deep in the interventricular septum
Study: NCT05535361

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Distraction Enterogenesis in Adult Patients with Short Bowel Syndrome
Description: The surgeon verifies the intestinal diameter and selects the appropriate device diameter size. The device is introduced into the lumen of the intestine and advanced about 5-10cm. The surgeon uses 4-0 sutures placed in the seromuscular layer to secure the XL1 Coil within the intestine. The surgeon places metal clips on proximal and distal sutures and in the mesentery adjacent to the XL1 Coil ends to mark the location for radiologic evaluation. The surgeon releases the XL1 Coil and closes the enterotomy.
Study: NCT05019456

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: COVID-19 Vaccine
Description: COVID-19 Vaccine (mRNA or J\&J)
Study: NCT06351293

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Defyne Treatment in Nasolabial Fold
Description: Defyne will be injected into left or right nasolabial fold, per randomization.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: RHA3 Treatment in Nasolabial Fold
Description: RHA3 will be injected into left or right nasolabial fold, per randomization.
Study: NCT05747924

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AOC 1020
Description: AOC 1020 will be administered via intravenous (IV) infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AOC 1020
Description: AOC 1020 will be administered via intravenous (IV) infusion
Study: NCT04507360

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Study 1, Content-as-usual
Description: The content page will not include any embedded Do-It-Yourself (DIY) tool.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Study 2, Control
Description: Participants in the Do-It-Yourself (DIY) control group will receive psychoeducation materials in W0. They will view content as usual (no DIY).
Study: NCT05747924

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AOC 1020
Description: AOC 1020 will be administered via intravenous (IV) infusion

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be administered via intravenous (IV) infusion
Study: NCT04507360

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Study 2, DIY tool without AI
Description: Participants in the Do-It-Yourself (DIY) tool without Artificial Intelligence (AI) group will be instructed to use the DIY tool 3 times a week.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Study 2, DIY tool with AI
Description: Participants in the Do-It-Yourself (DIY) tool with Artificial Intelligence (AI) group will be instructed to use the DIY tool with AI 3 times a week.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Study 1, Tailored Resources by Demographics
Description: Participants will be provided with links to MHA resources tailored to sexuality (Lesbian, Gay, Bisexual, Transgender, or Queer) status and age range.
Study: NCT05747924

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be administered via intravenous (IV) infusion
Study: NCT05769101

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Ingestion of a Post-Workout Supplement
Description: The Post-Workout Supplement is administered 15 minutes after the completion of training sessions. No supplementation is administered in non-training days. The Resistance Training is performed in alternate days. The training Protocol is: 10 minutes of standardized warm-up, Strength Circuit training using free weights (Alternate Box Step-Ups, Bench Press; Parallel Squat; Up-right Row; Deadlift; Alternate Lunges; Shoulder Press; Leg Extension). The participants perform 16 repetitions of each exercise, with 30 seconds rest and 3 minutes rest after every set. If they can complete 16 repetitions easily, 2.5 to 5 kg are added for the next set. Also, whole-body Perceptual Response is assessed using the 0-10 OMNI-RES Scale, after every set and 15 minutes after finishing.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Ingestion of a Maltodextrin Supplement
Description: The Maltodextrin Supplement is administered 15 minutes after the completion of training sessions. No supplementation is administered in non-training days. The Resistance Training is performed in alternate days. The training Protocol is: 10 minutes of standardized warm-up, Strength Circuit training using free weights (Alternate Box Step-Ups, Bench Press; Parallel Squat; Up-right Row; Deadlift; Alternate Lunges; Shoulder Press; Leg Extension). The participants perform 16 repetitions of each exercise, with 30 seconds rest and 3 minutes rest after every set. If they can complete 16 repetitions easily, 2.5 to 5 kg are added for the next set. Also, whole-body Perceptual Response is assessed using the 0-10 OMNI-RES Scale, after every set and 15 minutes after finishing.
Study: NCT06551012

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Nitrate-rich beetroot juice
Description: Participants will consume 2 x 70 ml bottles of nitrate-rich beetroot juice for a 7 day period prior to exercise testing

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Beetroot juice with nitrate extracted
Description: Participants will consume 2 x 70 ml bottles of beetroot juice with nitrate extracted for a 7 day period prior to exercise testing
Study: NCT06066567

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Interferential current stimulation
Description: IF Current parameters will be applied as follow: Amplitude modulated frequency (AMF) 30Hz, Autosweep-5 sec, Dose-15 minutes, type of current dynamic vector field (Mitra, 2006), three days per week over four weeks (Corrêa et al., 2016) and current intensity will be increased gradually, according to the subject's condition

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Draw- In exercises,,
Description: From prone position, participants will lay face down on the bed and flexed their hips and knees at 0°. A PBU will be positioned below the pubis symphysis with the decreasing edge consistent with the ASIS and will be overstated to 70 mmHg. The participants will be trained to gently draw in the lower part of the abdomen under the navel. In addition, while maintaining the neutral pelvic position, the movement of the upper part of the abdomen will be restricted so that the pressure will be decreased by approximately 10 mmHg. The participants will maintain this position for 10 s

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Draw- In exercises,,
Description: From prone position, participants will lay face down on the bed and flexed their hips and knees at 0°. A PBU will be positioned below the pubis symphysis with the decreasing edge consistent with the ASIS and will be overstated to 70 mmHg. The participants will be trained to gently draw in the lower part of the abdomen under the navel. In addition, while maintaining the neutral pelvic position, the movement of the upper part of the abdomen will be restricted so that the pressure will be decreased by approximately 10 mmHg. The participants will maintain this position for 10 s
Study: NCT04896294

Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Hygienic procedure (toothbrushing using HAP-containing toothpaste)
Description: Toothbrushing using standardised technique and pear-sized amount of HAP-containing toothpaste twice daily for 1 month.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Hygienic procedure (toothbrushing using Zn Mg HAP-containing)
Description: Toothbrushing using standardised technique and pear-sized amount of Zn Mg HAP-containing toothpaste twice daily for 1 month.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Hygienic procedure (toothbrushing using FAP-containing toothpaste)
Description: Toothbrushing using standardised technique and pear-sized amount of FAP-containing toothpaste twice daily for 1 month.
Study: NCT06305013

Intervention type: OTHER
Intervention: Pulseless electrical activity recognition
Description: The ability of nurses to recognize the pulseless electrical activity in the questionnaire (electronic survey)
Study: NCT04893291

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Everolimus Eluting Stent
Description: Patients assigned to this Arm will have an EES implanted after pre-dilatation, the angiography will be conducted as standard of care

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sirolimus Coated Balloon
Description: Patients assigned to this Arm will be treated with Magic Touch Drug Coated Balloon (DCB) after pre-dilatation, the angiography will be conducted as standard of care
Study: NCT05776303

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Good Bowls
Description: Healthy, frozen subsidized meals are made conveniently available on worksites.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Good Bowls
Description: Healthy, frozen subsidized meals are made conveniently available on worksites.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Good Bowls + App Nudges
Description: Healthy, frozen subsidized meals are made conveniently available on worksites.~Additionally, Bluetooth enabled beacons will be set up at each worksite that will send location specific messages to an individual's Smartphone via an App. These messages will include nutritional information, tips, and behavioral nudges.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Good Bowls + App Nudges
Description: Healthy, frozen subsidized meals are made conveniently available on worksites.~Additionally, Bluetooth enabled beacons will be set up at each worksite that will send location specific messages to an individual's Smartphone via an App. These messages will include nutritional information, tips, and behavioral nudges.
Study: NCT05594420

Intervention type: PROCEDURE
Intervention: Mitral valve replacement
Description: Mitral valve replacement through median sternotomy and minimally invasive approach

Intervention type: PROCEDURE
Intervention: Mitral valve replacement
Description: Mitral valve replacement through median sternotomy and minimally invasive approach
Study: NCT05225831

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Autologous CD19/CD22 Chimeric Antigen Receptor T-cells
Description: A single infusion of CD19 and CD22 CAR-T cells.
Study: NCT05013840

Intervention type: BEHAVIORAL
Intervention: Filling in an online survey
Description: Physicians are asked to fill in an online survey regarding 1) goals to treat patients with neuromodulation for pain, 2) factors that respondents expect to change according to neuromodulation for pain and 3) their definition of success of neuromodulation for pain.
Study: NCT05225831

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide,Fludarabine
Description: Given
Study: NCT06449885

Intervention type: OTHER
Intervention: patients receive optimal treatment or follow-up according to the characteristics of the disease
Description: Patients with MZL who are eligible for enrollment will be evaluated by the investigator and the enrolled patients will receive long-term follow-up after collecting medical history information, biological samples, and oncology data according to the study protocol. This study does not specify a detailed treatment modality, and patients receive optimal treatment or follow-up according to the characteristics of the disease.
Study: NCT06089421

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Genetic Information Assistant
Description: Participants assigned will receive a link to Genetic Information Assistant for pre-test counseling.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Telegenetics with UVA genetic counselor
Description: Participants assigned will have a pre-test counseling session via a telegentics visit with a genetic counselor.
Study: NCT05406037

Intervention type: BIOLOGICAL
Intervention: Venous sample
Description: at Day 0, Day 3, Day 7, Day 14, Day 28 (7 ml blood sample collecting on dry tube) D0 = Diagnostic day

Intervention type: BIOLOGICAL
Intervention: Venous sample
Description: at Day 0, Day 3, Day 7, Day 14, Day 28 (7 ml blood sample collecting on dry tube) D0 = Diagnostic day

Intervention type: BIOLOGICAL
Intervention: Venous sample
Description: at Day 0, Day 3, Day 7, Day 14, Day 28 (7 ml blood sample collecting on dry tube) D0 = Diagnostic day
Study: NCT05744050

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Low energy density lunch
Description: Particpants will be provided with a lunch low in energy density (\~1.1kcal/g)

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Medium energy density lunch
Description: Participants will be provided with a lunch medium in energy density(\~1.7kcal/g)
Study: NCT05521165

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: therapeutic exercises
Description: strengthening exercises for gluteus medius and APTA guided program for NSCLBP

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: therapeutic exercises
Description: strengthening exercises for gluteus medius and APTA guided program for NSCLBP
Study: NCT05744050

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High energy density lunch
Description: Participants will be provided with a lunch high in energy density (\~3kcal/g)
Study: NCT06129409

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NT-0796
Description: Orally administered capsules

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: NT-0796
Description: Orally administered capsules
Study: NCT06169215

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo collection of blood and urine samples

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biospecimen Collection
Description: Undergo collection of blood and urine samples

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Aspiration
Description: Undergo bone marrow aspiration

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Bone Marrow Aspiration
Description: Undergo bone marrow aspiration

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Biopsy
Description: Undergo bone marrow biopsy

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Bone Marrow Biopsy
Description: Undergo bone marrow biopsy

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bortezomib
Description: Given SC
Study: NCT04727008

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CXCR4 modified anti-BCMA CAR T cells
Description: intravenous infusion
Study: NCT05634122

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Description: Group treatment protocol of 8 weeks of 90 minutes sessions Session 1: Presentation of the general ACT therapy concept. Session 2: Value analysis I. Session 3: Value analysis II. Session 4: Value analysis third Session 5: Values and feelings. Session 6: Drink one direction. Session 7: Dare and change. Session 8: Ready to act with ACT. Treatment as usual (TAU) Standard pharmacological treatment for patients with chronic pain.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as Usual (TAU)
Description: Standard pharmacological treatment for patients with chronic pain
Study: NCT06169215

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bortezomib
Description: Given SC

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Computed Tomography
Description: Undergo CT

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Daratumumab
Description: Given SC

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Daratumumab
Description: Given SC
Study: NCT04422275

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Low-Concentration Essential Oil
Description: Low-concentration essential oil will include 0.1 ml of essential oil per jar.

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Low-Concentration Essential Oil
Description: Low-concentration essential oil will include 0.1 ml of essential oil per jar.
Study: NCT06169215

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daratumumab and Recombinant Human Hyaluronidase
Description: Given SC

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Daratumumab and Recombinant Human Hyaluronidase
Description: Given SC

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Given PO

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone
Description: Given PO

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lenalidomide
Description: Given PO
Study: NCT04601376

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mobile Monitoring Tool
Description: a text-messaged based outcomes collection system
Study: NCT06169215

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET
Study: NCT04644731

Intervention type: DEVICE
Intervention: Aquadex™ System
Description: Ultrafiltration for fluid removal
Study: NCT05619224

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neurodevelopmental stimulation + Oral stimulation
Description: Neurodevelopmental intervention seeks to reduce abnormal postures and movement patterns in premature infants, allowing them to experience physiological postures in flexion and receive sensory stimulation. To this is added oral stimulation.~These stimulations are performed on alternate days.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Oral stimulation
Description: This intervention consists of performing a sensorimotor stimulation of oral structures: stimulating for 7 minutes perioral structures( cheeks, lips and jaw)intraoral structures for 5 minutes and in the last 3 minutes non-nutritive suction stimulation with pacifier or finger.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Oral stimulation
Description: This intervention consists of performing a sensorimotor stimulation of oral structures: stimulating for 7 minutes perioral structures( cheeks, lips and jaw)intraoral structures for 5 minutes and in the last 3 minutes non-nutritive suction stimulation with pacifier or finger.
Study: NCT06169215

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Positron Emission Tomography
Description: Undergo PET
Study: NCT04325347

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Reality application
Description: Virtual Reality application with a VR goggle
Study: NCT04323475

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Bacteriophage cocktail spray
Description: Study intervention consists of a dosage-metered airless spray containing a cocktail of 14 bacteriophages at a concentration of 1.4 x 10\^8 PFU/mL for an effective dosage of 2.5 x10\^5 PFU/cm\^2 of burned area. The study intervention will be applied in conjunction with standard of care.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Xeroform
Description: Standard of care will consist of Xeroform primary dressing and Kenacomb topical antibiotic cream (for wounds with signs of localized infection)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Xeroform
Description: Standard of care will consist of Xeroform primary dressing and Kenacomb topical antibiotic cream (for wounds with signs of localized infection)
Study: NCT06169215

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Selinexor
Description: Given PO
Study: NCT05159180

Intervention type: DEVICE
Intervention: cardioz mapping
Description: Patients will be submitted to mapping of both voltage and tissue impedance.